3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Completed
2
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Other neoplasm
1
Conditions
Prostatic Neoplasms
2
Colonic Neoplasms
2
Rectal Neoplasms
1
Radiation Injuries
1
Precancerous Conditions
1
Neoplasms, Second Primary
1
Neoplasms
1
Head and Neck Neoplasms
1
Head and Neck Fibrosis
1
Erectile Dysfunction
1
Colorectal Neoplasms
1
Adenomatous Polyps
1
Interventions
Fluorouracil
128
Leucovorin
120
Oxaliplatin
101
Irinotecan
89
Bevacizumab
55
Cetuximab
44
Capecitabine
40
Folfox protocol
29
Panitumumab
22
Colonoscopy
17
Chemotherapy, Adjuvant
16
Floxuridine
15
Early Intervention, Educational
15
Erlotinib Hydrochloride
13
Surveys and Questionnaires
11
IFL protocol
11
Counseling
11
Celecoxib
11
Immunohistochemistry
10
Gemcitabine
10
Psychiatric Rehabilitation
9
Methods
8
Magnetic Resonance Spectroscopy
8
Gene Expression Profiling
8
Exercise
8
Dexamethasone
8
sargramostim
7
Sorafenib
7
Radiotherapy
7
Nivolumab
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Colonic Neoplasms
×
alpha-Tocopherol
×
Clear all
NCT03416777
2021-07-30
MeaTIc
Azienda Ospedaliero-Universitaria Careggi
Phase NA
Completed
103 enrolled
NCT00706121
2019-12-16
ACP
SWOG Cancer Research Network
Phase 3
Completed
8,094 enrolled
23 charts